Bellevue Asset Management - Bellevue Biotech Fund (CH) CHF Cls AA INC ANL RET (ADGLBA-SE) Q3 2024 Earnings

Aug 28Confirmed
Q1 1
Q2 2024
Q3 2024
-0.12
0.22
0.55
0.88

Details

Expected EPS
-0.11722368085411199
Actual EPS
-0.11722368085411199
Surprise EPS
0
Surprise Percent
+0%

Description

⁨Bellevue Asset Management - Bellevue Biotech Fund (CH) CHF Cls AA INC ANL RET⁩ (⁦ADGLBA-SE⁩) has reported earnings of ⁦-0.11722368085411199⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts